Orthogonal proteomics methods warrant the development of Duchenne muscular dystrophy biomarkers

BACKGROUND: Molecular components in blood, such as proteins, are used as biomarkers to detect or predict disease states, guide clinical interventions and aid in the development of therapies. While multiplexing proteomics methods promote discovery of such biomarkers, their translation to clinical use...

Descripción completa

Detalles Bibliográficos
Autores principales: Johansson, Camilla, Hunt, Helian, Signorelli, Mirko, Edfors, Fredrik, Hober, Andreas, Svensson, Anne-Sophie, Tegel, Hanna, Forstström, Björn, Aartsma-Rus, Annemieke, Niks, Erik, Spitali, Pietro, Uhlén, Mathias, Szigyarto, Cristina Al-Khalili
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258980/
https://www.ncbi.nlm.nih.gov/pubmed/37308827
http://dx.doi.org/10.1186/s12014-023-09412-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258980/
https://www.ncbi.nlm.nih.gov/pubmed/37308827
http://dx.doi.org/10.1186/s12014-023-09412-1

Ejemplares similares